title: Conserved oncogenic behavior of the FAM83 family regulates MAPK signaling in human cancer.
abstract: FAM83B (family with sequence similarity 83, member B) was recently identified as a novel oncogene involved in activating CRAF/MAPK signaling and driving epithelial cell transformation. FAM83B is one of eight members of a protein family (FAM83) characterized by a highly conserved domain of unknown function (DUF1669), which is necessary and sufficient to drive transformation. Here, it is demonstrated that additional FAM83 members also exhibit oncogenic properties and have significantly elevated levels of expression in multiple human tumor types using a TissueScan Cancer Survey Panel PCR array and database mining. Furthermore, modeling the observed tumor expression of FAM83A, FAM83C, FAM83D, or FAM83E promoted human mammary epithelial cell (HMEC) transformation, which correlated with the ability of each FAM83 member to bind CRAF (RAF1) and promote CRAF membrane localization. Conversely, ablation of FAM83A or FAM83D from breast cancer cells resulted in diminished MAPK signaling with marked suppression of growth in vitro and tumorigenicity in vivo. Importantly, each FAM83 member was determined to be elevated in at least one of 17 distinct tumor types examined, with FAM83A, FAM83B, and FAM83D most frequently overexpressed in several diverse tissue types. Finally, evidence suggests that elevated expression of FAM83 members is associated with elevated tumor grade and decreased overall survival.
  
  
  CONCLUSIONS
  FAM83 proteins represent a novel family of oncogenes suitable for the development of cancer therapies aimed at suppressing MAPK signaling.
authors.affiliation: Department of Pathology, and.
authors.forename: Rocky
authors.initials: R
authors.lastname: Cipriano
authors.affiliation: Department of Pathology, and.
authors.forename: Kristy L S
authors.initials: KL
authors.lastname: Miskimen
authors.affiliation: Department of Pathology, and.
authors.forename: Benjamin L
authors.initials: BL
authors.lastname: Bryson
authors.affiliation: Department of Pathology, and.
authors.forename: Chase R
authors.initials: CR
authors.lastname: Foy
authors.affiliation: Department of Pathology, and.
authors.forename: Courtney A
authors.initials: CA
authors.lastname: Bartel
authors.affiliation: Department of Pathology, and Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, Ohio mwj7@cwru.edu.
authors.forename: Mark W
authors.initials: MW
authors.lastname: Jackson
mesh_terms: D000818:Animals; D001943:Breast Neoplasms / Q000235:genetics* / Q000378:metabolism; D063646:Carcinogenesis / Q000235:genetics; D045744:Cell Line, Tumor; D002471:Cell Transformation, Neoplastic / Q000235:genetics; D004847:Epithelial Cells / Q000378:metabolism; D005260:Female; D006801:Humans; D042361:Mammary Glands, Human / Q000378:metabolism; D051379:Mice; D008819:Mice, Nude; D020928:Mitogen-Activated Protein Kinases / Q000235:genetics*; D009363:Neoplasm Proteins / Q000235:genetics*; D009857:Oncogenes / Q000235:genetics; D015398:Signal Transduction / Q000235:genetics*
chemical_list: D009363:Neoplasm Proteins; D020928:Mitogen-Activated Protein Kinases
references.citation: Oncogene. 2004 May 27;23(25):4477-87
references.pmid: 15064747
references.citation: Oncogene. 2007 May 14;26(22):3291-310
references.pmid: 17496923
references.citation: Neoplasia. 2005 Dec;7(12):1073-80
references.pmid: 16354590
references.citation: Oncogene. 2014 Jun 19;33(25):3298-306
references.pmid: 23912460
references.citation: Oncotarget. 2013 May;4(5):729-38
references.pmid: 23676467
references.citation: Cell. 2012 Apr 13;149(2):307-21
references.pmid: 22500798
references.citation: Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W289-94
references.pmid: 15980472
references.citation: Biochem Biophys Res Commun. 2008 Aug 8;372(4):756-60
references.pmid: 18514066
references.citation: Mol Carcinog. 2011 Apr;50(4):264-79
references.pmid: 20648549
references.citation: Nat Rev Drug Discov. 2005 Dec;4(12):988-1004
references.pmid: 16341064
references.citation: Neoplasia. 2007 Feb;9(2):166-80
references.pmid: 17356713
references.citation: Oncogene. 2008 Sep 18;27(41):5497-510
references.pmid: 18794884
references.citation: Cancer Res. 2006 Mar 15;66(6):3169-76
references.pmid: 16540668
references.citation: Cancer Res. 2007 Oct 15;67(20):9862-8
references.pmid: 17942917
references.citation: J Clin Invest. 2012 Sep;122(9):3211-20
references.pmid: 22886303
references.citation: J Clin Invest. 2012 Sep;122(9):3197-210
references.pmid: 22886302
references.citation: Nat Med. 2012 Jul;18(7):1052-9
references.pmid: 22683778
references.citation: Curr Biol. 2008 May 20;18(10):723-729
references.pmid: 18485706